ResearchOncologists' Knowledge and Attitudes Towards Providing Dietary Guidance to Patients with Cancer
ResearchValidation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in Patients with Multiple Myeloma Enrolled in the CARTITUDE-4 Trial
ResearchBody Composition Predicts Poor Outcomes and Reveals Immunometabolic Dysfunction via Single-Cell Profiling in Anti-BCMA CAR T-Treated Myeloma
ResearchDiabetes Mellitus in Multiple Myeloma and Related Plasma Cell Disorders: A Review of Risk, Prognosis, and Outcomes
ResearchDietary patterns among individuals with plasma cell disorders — opportunities for targeted interventions
ResearchA High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
ResearchFunctionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
ResearchIMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for newly diagnosed multiple myeloma
ResearchA differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients
ResearchDiagnosis Disclosure and Related Illness Experience in Patients With Multiple Myeloma and Precursor Plasma Cell Disorders
ResearchLow Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies
ResearchLenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool
ResearchA pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma